49 Series A Healthcare Investors — 28 Currently Deploying

Elevate Capital invests in underserved entrepreneurs—women, minorities, veterans, and those with limited regional access to capital—by providing venture capital and mentorship to h…

Offer founders pursuing their life's work an alternative to the hype cycle by providing long-term thinking and supporting category-defining companies across all sectors that will l…

Empowering historically excluded founders with capital, mentorship, and networks to build scalable companies in Fintech, SaaS, AI, Logistics, and Healthcare, leveraging 25+ years o…

NFX identifies and backs founders building companies with network effects. The fund emphasizes software development, founder support through content/tools, and emerging technologie…

Calibrate partners with elite technical founders to turn deep tech breakthroughs (AI, computer vision, autonomy, robotics) into scalable commercial advantages across transportation…

Investing in a future where people of color experience true agency and participation in the American economy through supporting entrepreneurs from overlooked communities.

Seed-stage generalist investor supporting ambitious founders building enduring businesses across the United States, with focus on Software, Healthcare, Financial Services, Marketpl…

SignalFire is a VC firm built like a tech company that combines AI tools, data infrastructure, and deep sector expertise with portfolio support to help founders scale faster. The f…

Partnering with ambitious early-stage founders building category-defining companies across enterprise and consumer sectors.

Data-driven, systematic approach to partnering with the world's most promising companies. AI and data science engine for underwriting enables quantitative decision-making across ve…

Partner with brilliant founders to bring things of real wonder into the world by backing innovative companies that upend the status quo across software, sustainability, and consume…

Early-stage VC investing in disruptive AI and Blockchain startups outside Silicon Valley, anchored in Texas and Central U.S., leading Seed and Series A rounds in capital-efficient …

Back founders who rewrite the rules and imagine what's next, with focus on early-stage companies demonstrating conviction-driven vision across multiple sectors and geographies.

Generalist fund backing fearless founders solving the hardest challenges facing humanity across AI transformation, fintech, healthcare, industrial digitization, labor & education, …

We identify and support visionaries transforming industries with the potential to better billions of lives. Bow identifies platform companies in industries being transformed by tec…

Correlation Ventures backs groundbreaking technology and data science companies that solve industry problems through rapid decision-making and industry-leading networks.

Invests in companies using technology to solve important problems in healthcare, artificial intelligence, cybersecurity, agriculture, transportation, and other sectors

Portfolia builds venture funds designed by and for women, open to all to back the companies shaping the future we want to see. Focus on high-growth sectors like women's health, gre…

We invest in under-resourced entrepreneurs including women of color led businesses seeking pre-seed, seed level or series A financing. Our mission is to bridge the gap in venture c…

We help founders build a healthier & more sustainable future by investing capital, time & belief to accelerate success. We invest in driven founders building pioneering companies t…

We invest in founders creating positive system change, focusing on three consumer-led mega trends: Life (access and affordability in essential products/services), Health (preventat…

Early stage, global investors backing ambitious founders from inception through seed with high-conviction investments in foundational technology, offering strategic guidance and go…

Invest in teams building AI and intelligent machines that unlock human potential by transforming foundational industries. AI and robotics will allow humanity to rethink and rebuild…

Investing in exceptional founders transforming healthcare by rebuilding healthcare's operating system with software, data, and AI. Focus on technology infrastructure across the $5.…

We work with founders driving structural change in two complex systems: healthcare and financial services. With unparalleled networks and decades of sector experience.

Multi-stage venture capital firm that goes beyond traditional VC playbook by providing entrepreneurs support of a global ecosystem, connecting innovators everywhere.

Building next-generation companies to enhance healthy lifespan by investing in transformative healthcare companies targeting age-related diseases and aging itself through biotechno…

Digital health and healthcare technology investments

Early-stage tech investments in the US and Israel, providing access and meaningful connections to help brilliant minds breakthrough.

Help great people build great businesses starting at seed stage, backing big ideas and swinging for the fences.

Daphni backs visionary entrepreneurs with deep conviction, supporting startups where vision meets conviction across diverse sectors.

Help support entrepreneurs building globally ambitious companies that matter. Focus on companies solving meaningful problems across diverse sectors and geographies.

Back deep-tech founders who pair technical ambition with decisive execution, providing value beyond capital through hands-on partnership and conviction-driven investing.

Partner with bold founders to build legendary companies across technology sectors

Build the capability and confidence of Victorians to create, scale and invest in technology-driven startups

Investing in early-stage technology companies primarily in Florida and the Southeast

To give investors access to the best possible venture deals. We partner with lead VCs, apply rigorous diligence, and make investing straightforward.

Our mission is to identify and support companies that live at the intersection of for-profit & for-good

Creates and retains highly paid, sustainable jobs by investing in and linking early-stage technology firms and established manufacturers with experts, universities, follow-on fundi…

We are high conviction, concentrated, patient investors. We believe in the federated VC model.

We invest in remarkable entrepreneurs working at the intersection of healthcare and technology

Partner with corporations, entrepreneurs, and investors to build scalable innovation systems and build new technology-enabled businesses, products, and services

Investing in technology startups that solve problems in emerging markets, particularly Latin America

We are a founder-first venture capital firm. We like bold ideas from brilliant people. We walk with our founders, all the way.

We back entrepreneurs at every stage of the startup journey, helping visionary founders build game-changing companies. We invest in what's next across multiple industries and suppo…

Investing in early-stage technology companies with a focus on underrepresented founders and inclusive innovation

Acceleration capital for early growth companies in healthcare and technology sectors throughout the Southeast

We actively partner with Carriers, Founders and Investors to change the way insurance, financial services, and healthcare sectors function

Blue Ivy Ventures provides Yale alumni accredited investors access to diversified venture capital investments co-invested alongside leading VC firms, combining a curated annual fun…

How many series a healthcare investors are actively deploying right now?

DryPowder tracks 49 series a healthcare funds. Of these, 28 are currently deploying capital based on recent fund closes, portfolio activity, and partner signals. Use DryPowder's fund matching to see which ones fit your specific startup.

What check size do series a healthcare VCs write?

Among 49 series a healthcare funds on DryPowder, check sizes run from $25K–$100M. Ranges vary by fund size, vintage, and whether the fund leads rounds. Each fund profile shows check size detail and lead preference.

How do I get a meeting with a series a healthcare VC?

A warm intro is still the fastest path. Most series a healthcare VCs on DryPowder do accept cold outreach or direct applications, but response rates vary widely by fund. Before reaching out, use DryPowder's AI matching to get a fit score and specific talking points. Founders who lead with thesis-aligned framing get significantly better response rates than those sending the same deck to every fund on a list.

How long does a Series A process typically take?

Series A processes average 4-6 months. Unlike seed, you will navigate formal partner meetings, IC presentations, data room reviews, and reference calls. First meeting to term sheet alone takes 6-10 weeks at most firms. Running a compressed, competitive process where you approach all target investors in the same short window tends to produce faster decisions and better terms than a sequential approach.

How many series a healthcare investors should I be talking to at once?

Most fundraisers recommend a parallel process: identify 20-40 target investors but approach your highest-fit funds first. Of the 28 series a healthcare funds currently deploying, not all will match your specific stage and sector. Use fund matching to find your top 10-15, approach those first, collect feedback, then go wider. Going to every fund simultaneously without qualifying first burns bridges and dilutes the urgency that helps close a round.

How is DryPowder different from building a VC list on LinkedIn or Crunchbase?

The fund list you build on LinkedIn or Crunchbase is roughly the same list every other founder is building. DryPowder adds three things a manual search cannot: deployment signals (which funds have recently closed new vehicles and are actively writing checks), AI thesis matching (which of the 49 series a healthcare funds actually fits your specific startup, ranked by fit), and verified partner contact details. The goal is 15 targeted, thesis-aligned pitches instead of 150 generic ones.